<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03372109</url>
  </required_header>
  <id_info>
    <org_study_id>CL092</org_study_id>
    <nct_id>NCT03372109</nct_id>
  </id_info>
  <brief_title>Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain</brief_title>
  <official_title>A Randomized Controlled Trial to Evaluate the Effects of Repeated Periods of Modified Fasting to Support Healthy Natural Weight Management and Prevention of Weight Gain in Overweight But Generally Healthy Adults Over the Winter Holiday Period</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Supplement Formulators, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Supplement Formulators, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to assess the effects of repeated periods of modified fasting in
      support of healthy weight management and prevention of weight gain over the winter holiday
      period (mid-November to early January) in comparison to regular diet and activity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized, placebo-controlled trial in which subjects assigned to the
      modified fasting cohort will undergo consecutive weekly cycles of modified fasting for two
      consecutive days.

      The primary objective is to assess the effects of repeated periods of modified fasting on
      body weight.

      The secondary objectives include assessment of the effects of modified fasting on percent
      body fat, waist circumference and fasting levels of hs-CRP (hs-C-reactive protein), IL-6
      (Interleukin-6), IL-8 (interleukin-8), IL-12 (interleukin-12), TNF-a (tumor necrosis
      factor-alpha), IGF-1 (insulin-like growth factor 1), IGFBP-1 (insulin-like growth
      factor-binding protein 1) , Total Cholesterol, LDL cholesterol, HDL cholesterol, Glucose,
      Triglyceride, Insulin, Vitamin-D, 25-Hydroxy,

      Participants will undergo assessments of blood tests, vital signs, BMI, body weight, waist
      circumference and percent body fat.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 14, 2017</start_date>
  <completion_date type="Actual">March 22, 2018</completion_date>
  <primary_completion_date type="Actual">January 23, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body weight</measure>
    <time_frame>52 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hs-CRP</measure>
    <time_frame>52 days</time_frame>
    <description>hs-C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-6</measure>
    <time_frame>52 days</time_frame>
    <description>Interleukin-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-8</measure>
    <time_frame>52 days</time_frame>
    <description>Interleukin-8</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IL-12</measure>
    <time_frame>52 days</time_frame>
    <description>Interleukin-12</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TNF-a</measure>
    <time_frame>52 days</time_frame>
    <description>Tumor necrosis factor alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IGF-1</measure>
    <time_frame>52 days</time_frame>
    <description>Insulin-like growth factor 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IGFBP-1</measure>
    <time_frame>52 days</time_frame>
    <description>Insulin-like growth factor binding protein 1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Cholesterol</measure>
    <time_frame>52 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LDL-c</measure>
    <time_frame>52 days</time_frame>
    <description>LDL Cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HDL-c</measure>
    <time_frame>52 days</time_frame>
    <description>HDL Cholesterol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucose</measure>
    <time_frame>52 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglycerides</measure>
    <time_frame>52 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Insulin</measure>
    <time_frame>52 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vitamin D, 25-Hydroxy</measure>
    <time_frame>52 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Percent body fat</measure>
    <time_frame>52 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>52 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">23</enrollment>
  <condition>Body Weight Changes</condition>
  <arm_group>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary Supplements administered daily for 52 days with a meal replacement shake administered two days per week for the study duration</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Multivitamin tablet administered daily for 52 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Meal replacement shake</intervention_name>
    <description>Meal replacement shake taken two days per week during the modified fasting periods</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamin and mineral capsules</intervention_name>
    <description>Multivitamin/mineral supplement</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Fish oil with sesame lignans and olive extract softgel</intervention_name>
    <description>Wild Fish Oil Concentrate 2000mg, Olive Extract 300mg, Sesame seed lignan extract 10mg/2 softgels</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Prebiotic Chewable tablet</intervention_name>
    <description>Prebiotic Fiber 1,400 mg/tablet</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Clove Extract and Maqui Berry extract capsule</intervention_name>
    <description>Clove extract 250mg and maqui berry extract 200mg/capsule</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>.Whole Food Blend capsule</intervention_name>
    <description>Whole food blend 1000mg/3 capsules</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Turmeric extract capsule</intervention_name>
    <description>Turmeric 25:1 extract 400mg/capsule</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>European White Kidney Bean capsule</intervention_name>
    <description>White kidney bean extract 100mg/capsule</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Saffron extract capsule</intervention_name>
    <description>Saffron extract 88.25mg/capsule</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Ubiquinol with Fulvic acid complex softgel</intervention_name>
    <description>Ubiquinol 100mg and Fulvic Acid complex 100mg/softgel</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Calcium with Hesperidin and gynostemma extract tablet</intervention_name>
    <description>Calcium 130mg. hesperidin 500mg and gynostemma extract 450mg/ tablet</description>
    <arm_group_label>Modified Fasting Arm</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Multivitamin and mineral supplement</intervention_name>
    <description>Multivitamin and multimineral supplement</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ambulatory, male or female, 21-65 years of age

          -  A body mass index (BMI) of 23‒34.9

          -  Generally healthy and having no significant difficulty with digestion of food

          -  Has been generally weight stable for the past six months

          -  Willing to discontinue use of any (non-study) multivitamin or Vitamin D supplements
             during the study

          -  Willing and able to give written informed consent

          -  Clearly understands the procedures and study requirements

          -  Willing and able to comply with all study procedures, including following the
             recommendations to maintain their usual diet and regular activity, as per protocol

          -  Able to communicate, including reading, in English

        Primary Exclusion Criteria:

          -  Having smoked any cigarette, electronic cigarette, cigar, pipe, or used a recreational
             drug in the past 30 days

          -  History of allergy or sensitivity to any component of the study products including
             milk, soy and almonds

          -  Donation of blood with 30 days prior to screening/baseline

          -  Inability to provide a venous blood sample

          -  Participation in another study within 30 days prior to baseline/screening

          -  Being pregnant or planning on becoming pregnant during study participation; or breast
             feeding

          -  Having been diagnosed, received medical treatment or taking medication daily for the
             following medical condition(s):

          -  Diabetes mellitus

          -  Eating disorder

          -  Acute or chronic inflammatory disease or autoimmune disease

          -  Cardiovascular disease

          -  Gastrointestinal disease including gallbladder problems, gallstones or biliary tract
             obstruction

          -  Thyroid disease (unless on a stable dose of medication for 3 months prior to screening
             and unlikely to change medication or dose during the study)

          -  Hypertension (unless on a stable dose of medication for 3 months prior to screening
             and unlikely to change medication or dose during the study)

          -  Psychiatric disorder

          -  Neurologic condition/disease

          -  Cancer (unless skin cancer other than melanoma which has been treated &gt; 3 years prior
             to Baseline/screening)

          -  Active or chronic liver, pancreatic and kidney disease

          -  Blood coagulation disorder

          -  Other condition or medication use that would preclude participation in the study in
             the judgment of the investigator/sub-investigator (Sub-I)

          -  Currently taking or having taken within the 30 days prior to screening/baseline any
             hormone replacement therapy (including DHEA (dehydroepiandrosterone), estrogen,
             progesterone, or testosterone; except those utilized as a method of birth control and
             which have been taken for &gt; 3 months, with no anticipated change for the duration of
             the study)

          -  Currently taking any of the nutritional supplements used in the study and unwilling to
             discontinue use at least 14 days prior to screening.

          -  Currently taking a medication or nutritional supplement specifically for weight loss
             and unwilling to discontinue use 14 days prior to the first dosing of study
             supplements

          -  Currently participating in a weight loss program and unwilling to discontinue
             participation prior to enrollment into the study

          -  Currently taking an anti-coagulant, anti-platelet medication or a glucose lowering
             medication

          -  Having had a surgical procedure or having an internal medical device which, in the
             judgment of the PI/Sub-I, would preclude participation in the study

          -  Having abnormal screening laboratory test values including bilirubin &gt; 2.5 x ULN
             (upper limit of normal), AST/SGOT(aspartate aminotransferase/serum glutamin
             oxaloacetic transaminase) and ALT/SGPT (alanine aminotransferase/serum glutamic
             pyruvic transaminase) &gt; 2.5 x ULN, serum creatinine &gt; 1.5 mg/dL, blood glucose &lt; 85
             mg/dL or &gt; 125 mg/dL, and TSH(thyroid stimulating hormone) &gt; 4.12 µIU/mL, or other lab
             test result(s) that would preclude study participation in the judgement of the
             PI/Sub-I

          -  Having blood pressure readings at Baseline/screening &gt; 140 systolic or &gt; 90 diastolic
             on two consecutive readings unless permitted to proceed to the next visit in the
             judgment of the PI/Sub-I

          -  Currently consumes more than 7 standard alcoholic drinks per week for women and 14
             drinks per week for men (a standard alcoholic drink is defined as one bottle/can of
             beer, one glass of wine, or one ounce of hard liquor)

          -  Unable or unwilling to avoid consuming grapefruit juice or fresh grapefruit, Seville
             oranges and tangelos

          -  Having any other circumstance that precludes study participation in the judgment of
             the PI/Sub-I including use of other nutritional supplements which will be evaluated on
             a case-by-case basis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Steven Joyal, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>LIfe Extension</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Life Extension Clinical Research, Inc.</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://aibmr.com/gras-affirmation-and-the-development-of-functional-foods/</url>
    <description>AIBMR.GRAS Self-determination Inventory Database. Coenzyme Q10.</description>
  </link>
  <link>
    <url>http://labeling.pfizer.com/ShowLabeling.aspx?id=3772</url>
    <description>Centrum</description>
  </link>
  <link>
    <url>https://medlineplus.gov/druginfo/meds/a607065.html</url>
    <description>Omega-3 Fatty Acids</description>
  </link>
  <link>
    <url>http://www.lifeextension.com/Vitamins-Supplements/item02114/Two-Per-Day-Capsules</url>
    <description>Two-Per-Day capsules</description>
  </link>
  <link>
    <url>http://www.naturalin.com/plant-extract/gynostemma-extract.html</url>
    <description>Gynostemma extract</description>
  </link>
  <reference>
    <citation>Alvarado J, Schoenlau F, Leschot A, Salgad AM, Vigil Portales P. Delphinol® standardized maqui berry extract significantly lowers blood glucose and improves blood lipid profile in prediabetic individuals in three-month clinical trial. Panminerva Med. 2016 Sep;58(3 Suppl 1):1-6.</citation>
    <PMID>27820958</PMID>
  </reference>
  <reference>
    <citation>Alvarado JL, Leschot A, Olivera-Nappa Á, Salgado AM, Rioseco H, Lyon C, Vigil P. Delphinidin-Rich Maqui Berry Extract (Delphinol®) Lowers Fasting and Postprandial Glycemia and Insulinemia in Prediabetic Individuals during Oral Glucose Tolerance Tests. Biomed Res Int. 2016;2016:9070537. doi: 10.1155/2016/9070537. Epub 2016 Nov 29.</citation>
    <PMID>28025651</PMID>
  </reference>
  <reference>
    <citation>Aranganathan S, Nalini N. Efficacy of the potential chemopreventive agent, hesperetin (citrus flavanone), on 1,2-dimethylhydrazine induced colon carcinogenesis. Food Chem Toxicol. 2009 Oct;47(10):2594-600. doi: 10.1016/j.fct.2009.07.019. Epub 2009 Jul 24.</citation>
    <PMID>19632289</PMID>
  </reference>
  <reference>
    <citation>Bales CW, Kraus WE. Caloric restriction: implications for human cardiometabolic health. J Cardiopulm Rehabil Prev. 2013 Jul-Aug;33(4):201-8. doi: 10.1097/HCR.0b013e318295019e. Review.</citation>
    <PMID>23748374</PMID>
  </reference>
  <reference>
    <citation>Barger JL, Kayo T, Pugh TD, Prolla TA, Weindruch R. Short-term consumption of a resveratrol-containing nutraceutical mixture mimics gene expression of long-term caloric restriction in mouse heart. Exp Gerontol. 2008 Sep;43(9):859-66. doi: 10.1016/j.exger.2008.06.013. Epub 2008 Jul 9.</citation>
    <PMID>18657603</PMID>
  </reference>
  <reference>
    <citation>Barrett ML, Udani JK. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J. 2011 Mar 17;10:24. doi: 10.1186/1475-2891-10-24. Review.</citation>
    <PMID>21414227</PMID>
  </reference>
  <reference>
    <citation>Bitler C, Matt K, Irving M, et al. Olive extract supplement decreases pain and improves daily activities in adults with osteoarthritis and decreases plasma homocysteine in those with rheumatoid arthritis. Nutrition Research. 27(8):470-77.2007</citation>
  </reference>
  <reference>
    <citation>Bonakdar RA, Guarneri E. Coenzyme Q10. Am Fam Physician. 2005 Sep 15;72(6):1065-70. Review.</citation>
    <PMID>16190504</PMID>
  </reference>
  <reference>
    <citation>Buchowski MS, Hongu N, Acra S, Wang L, Warolin J, Roberts LJ 2nd. Effect of modest caloric restriction on oxidative stress in women, a randomized trial. PLoS One. 2012;7(10):e47079. doi: 10.1371/journal.pone.0047079. Epub 2012 Oct 5.</citation>
    <PMID>23071718</PMID>
  </reference>
  <reference>
    <citation>Carai MA, Fantini N, Loi B, Colombo G, Riva A, Morazzoni P. Potential efficacy of preparations derived from Phaseolus vulgaris in the control of appetite, energy intake, and carbohydrate metabolism. Diabetes Metab Syndr Obes. 2009 Sep 7;2:145-53.</citation>
    <PMID>21437128</PMID>
  </reference>
  <reference>
    <citation>Carling D, Sanders MJ, Woods A. The regulation of AMP-activated protein kinase by upstream kinases. Int J Obes (Lond). 2008 Sep;32 Suppl 4:S55-9. doi: 10.1038/ijo.2008.124. Review.</citation>
    <PMID>18719600</PMID>
  </reference>
  <reference>
    <citation>Cerdá B, Cerón JJ, Tomás-Barberán FA, Espín JC. Repeated oral administration of high doses of the pomegranate ellagitannin punicalagin to rats for 37 days is not toxic. J Agric Food Chem. 2003 May 21;51(11):3493-501.</citation>
    <PMID>12744688</PMID>
  </reference>
  <reference>
    <citation>Chan DC, Watts GF, Mori TA, Barrett PH, Redgrave TG, Beilin LJ. Randomized controlled trial of the effect of n-3 fatty acid supplementation on the metabolism of apolipoprotein B-100 and chylomicron remnants in men with visceral obesity. Am J Clin Nutr. 2003 Feb;77(2):300-7.</citation>
    <PMID>12540386</PMID>
  </reference>
  <reference>
    <citation>Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001 Jul-Aug;21(4B):2895-900.</citation>
    <PMID>11712783</PMID>
  </reference>
  <reference>
    <citation>Chen HH, Chen YK, Chang HC, et al. Immunomodulatory Effects of Xylooligosaccharides. Food Science and Technology Research. 18(2):195-9. 2012.</citation>
  </reference>
  <reference>
    <citation>Cherif S, Rahal N, Haouala M, Hizaoui B, Dargouth F, Gueddiche M, Kallel Z, Balansard G, Boukef K. [A clinical trial of a titrated Olea extract in the treatment of essential arterial hypertension]. J Pharm Belg. 1996 Mar-Apr;51(2):69-71. French.</citation>
    <PMID>8786521</PMID>
  </reference>
  <reference>
    <citation>Chiranthanut N, Teekachunhatean S, Panthong A, Khonsung P, Kanjanapothi D, Lertprasertsuk N. Toxicity evaluation of standardized extract of Gynostemma pentaphyllum Makino. J Ethnopharmacol. 2013 Aug 26;149(1):228-34. doi: 10.1016/j.jep.2013.06.027. Epub 2013 Jun 21.</citation>
    <PMID>23796877</PMID>
  </reference>
  <reference>
    <citation>Coles, L.S., and Harris, S.B. Co Q-10 and lifespan extension, in: Advances in Anti-Aging Medicine, Vol 1, by R. Klatz, Mary Ann Liebert, Inc., Larchmont, New York, 1996</citation>
  </reference>
  <reference>
    <citation>Conley M, Le Fevre L, Haywood C, Proietto J. Is two days of intermittent energy restriction per week a feasible weight loss approach in obese males? A randomised pilot study. Nutr Diet. 2018 Feb;75(1):65-72. doi: 10.1111/1747-0080.12372. Epub 2017 Aug 9.</citation>
    <PMID>28791787</PMID>
  </reference>
  <reference>
    <citation>D'Argenio G, Mazzacca G. Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer. Adv Exp Med Biol. 1999;472:149-58. Review.</citation>
    <PMID>10736623</PMID>
  </reference>
  <reference>
    <citation>Davinelli S, Bertoglio JC, Zarrelli A, Pina R, Scapagnini G. A Randomized Clinical Trial Evaluating the Efficacy of an Anthocyanin-Maqui Berry Extract (Delphinol®) on Oxidative Stress Biomarkers. J Am Coll Nutr. 2015;34 Suppl 1:28-33. doi: 10.1080/07315724.2015.1080108.</citation>
    <PMID>26400431</PMID>
  </reference>
  <reference>
    <citation>de Bock M, Derraik JG, Brennan CM, Biggs JB, Morgan PE, Hodgkinson SC, Hofman PL, Cutfield WS. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS One. 2013;8(3):e57622. doi: 10.1371/journal.pone.0057622. Epub 2013 Mar 13.</citation>
    <PMID>23516412</PMID>
  </reference>
  <reference>
    <citation>de Vries W, Stouthamer AH. Pathway of glucose fermentation in relation to the taxonomy of bifidobacteria. J Bacteriol. 1967 Feb;93(2):574-6.</citation>
    <PMID>6020562</PMID>
  </reference>
  <reference>
    <citation>Dueñas M, Muñoz-González I, Cueva C, Jiménez-Girón A, Sánchez-Patán F, Santos-Buelga C, Moreno-Arribas MV, Bartolomé B. A survey of modulation of gut microbiota by dietary polyphenols. Biomed Res Int. 2015;2015:850902. doi: 10.1155/2015/850902. Epub 2015 Feb 22. Review.</citation>
    <PMID>25793210</PMID>
  </reference>
  <reference>
    <citation>El-Marasy SA, Abdallah HM, El-Shenawy SM, El-Khatib AS, El-Shabrawy OA, Kenawy SA. Anti-depressant effect of hesperidin in diabetic rats. Can J Physiol Pharmacol. 2014 Nov;92(11):945-52. doi: 10.1139/cjpp-2014-0281. Epub 2014 Sep 19.</citation>
    <PMID>25358020</PMID>
  </reference>
  <reference>
    <citation>Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R. Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 1993 Aug;12(4):225-30.</citation>
    <PMID>8218595</PMID>
  </reference>
  <reference>
    <citation>Esposito K, Kastorini CM, Panagiotakos DB, Giugliano D. Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab Syndr Relat Disord. 2011 Feb;9(1):1-12. doi: 10.1089/met.2010.0031. Epub 2010 Oct 25. Review.</citation>
    <PMID>20973675</PMID>
  </reference>
  <reference>
    <citation>Fantini N, Cabras C, Lobina C, Colombo G, Gessa GL, Riva A, Donzelli F, Morazzoni P, Bombardelli E, Carai MA. Reducing effect of a Phaseolus vulgaris dry extract on food intake, body weight, and glycemia in rats. J Agric Food Chem. 2009 Oct 14;57(19):9316-23. doi: 10.1021/jf900711z.</citation>
    <PMID>19731962</PMID>
  </reference>
  <reference>
    <citation>Garg A, Garg S, Zaneveld LJ, Singla AK. Chemistry and pharmacology of the Citrus bioflavonoid hesperidin. Phytother Res. 2001 Dec;15(8):655-69. Review.</citation>
    <PMID>11746857</PMID>
  </reference>
  <reference>
    <citation>Gauhar R, Hwang SL, Jeong SS, Kim JE, Song H, Park DC, Song KS, Kim TY, Oh WK, Huh TL. Heat-processed Gynostemma pentaphyllum extract improves obesity in ob/ob mice by activating AMP-activated protein kinase. Biotechnol Lett. 2012 Sep;34(9):1607-16. doi: 10.1007/s10529-012-0944-1. Epub 2012 May 11.</citation>
    <PMID>22576281</PMID>
  </reference>
  <reference>
    <citation>Ghasemi T, Abnous K, Vahdati F, Mehri S, Razavi BM, Hosseinzadeh H. Antidepressant Effect of Crocus sativus Aqueous Extract and its Effect on CREB, BDNF, and VGF Transcript and Protein Levels in Rat Hippocampus. Drug Res (Stuttg). 2015 Jul;65(7):337-43. doi: 10.1055/s-0034-1371876. Epub 2014 Apr 2.</citation>
    <PMID>24696423</PMID>
  </reference>
  <reference>
    <citation>Gout B, Bourges C, Paineau-Dubreuil S. Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women. Nutr Res. 2010 May;30(5):305-13. doi: 10.1016/j.nutres.2010.04.008.</citation>
    <PMID>20579522</PMID>
  </reference>
  <reference>
    <citation>Griffin MD, Sanders TA, Davies IG, Morgan LM, Millward DJ, Lewis F, Slaughter S, Cooper JA, Miller GJ, Griffin BA. Effects of altering the ratio of dietary n-6 to n-3 fatty acids on insulin sensitivity, lipoprotein size, and postprandial lipemia in men and postmenopausal women aged 45-70 y: the OPTILIP Study. Am J Clin Nutr. 2006 Dec;84(6):1290-8.</citation>
    <PMID>17158408</PMID>
  </reference>
  <reference>
    <citation>Handler N, Jaeger W, Puschacher H, Leisser K, Erker T. Synthesis of novel curcumin analogues and their evaluation as selective cyclooxygenase-1 (COX-1) inhibitors. Chem Pharm Bull (Tokyo). 2007 Jan;55(1):64-71.</citation>
    <PMID>17202703</PMID>
  </reference>
  <reference>
    <citation>Hansen CH, Frøkiær H, Christensen AG, Bergström A, Licht TR, Hansen AK, Metzdorff SB. Dietary xylooligosaccharide downregulates IFN-γ and the low-grade inflammatory cytokine IL-1β systemically in mice. J Nutr. 2013 Apr;143(4):533-40. doi: 10.3945/jn.112.172361. Epub 2013 Feb 20.</citation>
    <PMID>23427328</PMID>
  </reference>
  <reference>
    <citation>Hardie DG. AMP-activated protein kinase: a key system mediating metabolic responses to exercise. Med Sci Sports Exerc. 2004 Jan;36(1):28-34. Review.</citation>
    <PMID>14707764</PMID>
  </reference>
  <reference>
    <citation>Hardie DG. AMPK: a key regulator of energy balance in the single cell and the whole organism. Int J Obes (Lond). 2008 Sep;32 Suppl 4:S7-12. doi: 10.1038/ijo.2008.116. Review.</citation>
    <PMID>18719601</PMID>
  </reference>
  <reference>
    <citation>Hardie DG, Ross FA, Hawley SA. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol. 2012 Mar 22;13(4):251-62. doi: 10.1038/nrm3311. Review.</citation>
    <PMID>22436748</PMID>
  </reference>
  <reference>
    <citation>Hardie DG. Sensing of energy and nutrients by AMP-activated protein kinase. Am J Clin Nutr. 2011 Apr;93(4):891S-6. doi: 10.3945/ajcn.110.001925. Epub 2011 Feb 16. Review.</citation>
    <PMID>21325438</PMID>
  </reference>
  <reference>
    <citation>Hausenblas HA, Heekin K, Mutchie HL, Anton S. A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes. J Integr Med. 2015 Jul;13(4):231-40. doi: 10.1016/S2095-4964(15)60176-5. Review.</citation>
    <PMID>26165367</PMID>
  </reference>
  <reference>
    <citation>Hausenblas HA, Saha D, Dubyak PJ, Anton SD. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. J Integr Med. 2013 Nov;11(6):377-83. doi: 10.3736/jintegrmed2013056.</citation>
    <PMID>24299602</PMID>
  </reference>
  <reference>
    <citation>Heilbronn LK, Clifton PM. C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss. J Nutr Biochem. 2002 Jun;13(6):316-321.</citation>
    <PMID>12088796</PMID>
  </reference>
  <reference>
    <citation>Henke BR, Sparks SM. Glycogen phosphorylase inhibitors. Mini Rev Med Chem. 2006 Aug;6(8):845-57. Review.</citation>
    <PMID>16918491</PMID>
  </reference>
  <reference>
    <citation>Hidalgo J, Flores C, Hidalgo MA, Perez M, Yañez A, Quiñones L, Caceres DD, Burgos RA. Delphinol® standardized maqui berry extract reduces postprandial blood glucose increase in individuals with impaired glucose regulation by novel mechanism of sodium glucose cotransporter inhibition. Panminerva Med. 2014 Jun;56(2 Suppl 3):1-7.</citation>
    <PMID>24861886</PMID>
  </reference>
  <reference>
    <citation>Hokayem M, Blond E, Vidal H, Lambert K, Meugnier E, Feillet-Coudray C, Coudray C, Pesenti S, Luyton C, Lambert-Porcheron S, Sauvinet V, Fedou C, Brun JF, Rieusset J, Bisbal C, Sultan A, Mercier J, Goudable J, Dupuy AM, Cristol JP, Laville M, Avignon A. Grape polyphenols prevent fructose-induced oxidative stress and insulin resistance in first-degree relatives of type 2 diabetic patients. Diabetes Care. 2013 Jun;36(6):1454-61. doi: 10.2337/dc12-1652. Epub 2012 Dec 28.</citation>
    <PMID>23275372</PMID>
  </reference>
  <reference>
    <citation>Hosoe K, Kitano M, Kishida H, Kubo H, Fujii K, Kitahara M. Study on safety and bioavailability of ubiquinol (Kaneka QH) after single and 4-week multiple oral administration to healthy volunteers. Regul Toxicol Pharmacol. 2007 Feb;47(1):19-28. Epub 2006 Aug 21.</citation>
    <PMID>16919858</PMID>
  </reference>
  <reference>
    <citation>Hosseini B, Saedisomeolia A, Wood LG, Yaseri M, Tavasoli S. Effects of pomegranate extract supplementation on inflammation in overweight and obese individuals: A randomized controlled clinical trial. Complement Ther Clin Pract. 2016 Feb;22:44-50. doi: 10.1016/j.ctcp.2015.12.003. Epub 2015 Dec 12.</citation>
    <PMID>26850805</PMID>
  </reference>
  <reference>
    <citation>Huyen VT, Phan DV, Thang P, Hoa NK, Ostenson CG. Antidiabetic effect of Gynostemma pentaphyllum tea in randomly assigned type 2 diabetic patients. Horm Metab Res. 2010 May;42(5):353-7. doi: 10.1055/s-0030-1248298. Epub 2010 Mar 8.</citation>
    <PMID>20213586</PMID>
  </reference>
  <reference>
    <citation>Ikematsu H, Nakamura K, Harashima S, Fujii K, Fukutomi N. Safety assessment of coenzyme Q10 (Kaneka Q10) in healthy subjects: a double-blind, randomized, placebo-controlled trial. Regul Toxicol Pharmacol. 2006 Apr;44(3):212-8. Epub 2006 Jan 23.</citation>
    <PMID>16431002</PMID>
  </reference>
  <reference>
    <citation>Jain I, Kumar V, Satyanarayana T. Xylooligosaccharides: an economical prebiotic from agroresidues and their health benefits. Indian J Exp Biol. 2015 Mar;53(3):131-42. Review.</citation>
    <PMID>25872243</PMID>
  </reference>
  <reference>
    <citation>NM J, RM R, G G, Maliakel B, D S, IM K. Beyond the flavour: a de-flavoured polyphenol rich extract of clove buds (Syzygium aromaticum L) as a novel dietary antioxidant ingredient. Food Funct. 2015 Oct;6(10):3373-82. doi: 10.1039/c5fo00682a.</citation>
    <PMID>26273738</PMID>
  </reference>
  <reference>
    <citation>Kaats GR, Miller H, Preuss HG, Stohs SJ. A 60day double-blind, placebo-controlled safety study involving Citrus aurantium (bitter orange) extract. Food Chem Toxicol. 2013 May;55:358-62. doi: 10.1016/j.fct.2013.01.013. Epub 2013 Jan 25.</citation>
    <PMID>23354394</PMID>
  </reference>
  <reference>
    <citation>Kato M, Tani T, Terahara N, Tsuda T. The Anthocyanin Delphinidin 3-Rutinoside Stimulates Glucagon-Like Peptide-1 Secretion in Murine GLUTag Cell Line via the Ca2+/Calmodulin-Dependent Kinase II Pathway. PLoS One. 2015 May 11;10(5):e0126157. doi: 10.1371/journal.pone.0126157. eCollection 2015.</citation>
    <PMID>25962102</PMID>
  </reference>
  <reference>
    <citation>Kamaraj S, Ramakrishnan G, Anandakumar P, Jagan S, Devaki T. Antioxidant and anticancer efficacy of hesperidin in benzo(a)pyrene induced lung carcinogenesis in mice. Invest New Drugs. 2009 Jun;27(3):214-22. doi: 10.1007/s10637-008-9159-7. Epub 2008 Aug 13.</citation>
    <PMID>18704264</PMID>
  </reference>
  <reference>
    <citation>Khanna D, Sethi G, Ahn KS, Pandey MK, Kunnumakkara AB, Sung B, Aggarwal A, Aggarwal BB. Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol. 2007 Jun;7(3):344-51. Epub 2007 May 1. Review.</citation>
    <PMID>17475558</PMID>
  </reference>
  <reference>
    <citation>Khoo J, Piantadosi C, Duncan R, Worthley SG, Jenkins A, Noakes M, Worthley MI, Lange K, Wittert GA. Comparing effects of a low-energy diet and a high-protein low-fat diet on sexual and endothelial function, urinary tract symptoms, and inflammation in obese diabetic men. J Sex Med. 2011 Oct;8(10):2868-75. doi: 10.1111/j.1743-6109.2011.02417.x. Epub 2011 Aug 5.</citation>
    <PMID>21819545</PMID>
  </reference>
  <reference>
    <citation>Khurana S, Venkataraman K, Hollingsworth A, Piche M, Tai TC. Polyphenols: benefits to the cardiovascular system in health and in aging. Nutrients. 2013 Sep 26;5(10):3779-827. doi: 10.3390/nu5103779. Review.</citation>
    <PMID>24077237</PMID>
  </reference>
  <reference>
    <citation>Kim JY, Jung KJ, Choi JS, Chung HY. Modulation of the age-related nuclear factor-kappaB (NF-kappaB) pathway by hesperetin. Aging Cell. 2006 Oct;5(5):401-11. Epub 2006 Aug 25.</citation>
    <PMID>16939486</PMID>
  </reference>
  <reference>
    <citation>Kim YJ, Kim HJ, No JK, Chung HY, Fernandes G. Anti-inflammatory action of dietary fish oil and calorie restriction. Life Sci. 2006 Apr 18;78(21):2523-32. Epub 2006 Jan 24.</citation>
    <PMID>16438990</PMID>
  </reference>
  <reference>
    <citation>Kleemann R, van Erk M, Verschuren L, van den Hoek AM, Koek M, Wielinga PY, Jie A, Pellis L, Bobeldijk-Pastorova I, Kelder T, Toet K, Wopereis S, Cnubben N, Evelo C, van Ommen B, Kooistra T. Time-resolved and tissue-specific systems analysis of the pathogenesis of insulin resistance. PLoS One. 2010 Jan 21;5(1):e8817. doi: 10.1371/journal.pone.0008817.</citation>
    <PMID>20098690</PMID>
  </reference>
  <reference>
    <citation>Komaroff AL. The Microbiome and Risk for Obesity and Diabetes. JAMA. 2017 Jan 24;317(4):355-356. doi: 10.1001/jama.2016.20099.</citation>
    <PMID>28006047</PMID>
  </reference>
  <reference>
    <citation>Lee SH, Min KJ. Caloric restriction and its mimetics. BMB Rep. 2013 Apr;46(4):181-7. Review.</citation>
    <PMID>23615258</PMID>
  </reference>
  <reference>
    <citation>Li C, Schluesener H. Health-promoting effects of the citrus flavanone hesperidin. Crit Rev Food Sci Nutr. 2017 Feb 11;57(3):613-631. Review.</citation>
    <PMID>25675136</PMID>
  </reference>
  <reference>
    <citation>Li JJ, Huang CJ, Xie D. Anti-obesity effects of conjugated linoleic acid, docosahexaenoic acid, and eicosapentaenoic acid. Mol Nutr Food Res. 2008 Jun;52(6):631-45. doi: 10.1002/mnfr.200700399. Review.</citation>
    <PMID>18306430</PMID>
  </reference>
  <reference>
    <citation>Li M, Lin XF, Lu J, Zhou BR, Luo D. Hesperidin ameliorates UV radiation-induced skin damage by abrogation of oxidative stress and inflammatory in HaCaT cells. J Photochem Photobiol B. 2016 Dec;165:240-245. doi: 10.1016/j.jphotobiol.2016.10.037. Epub 2016 Nov 1.</citation>
    <PMID>27816646</PMID>
  </reference>
  <reference>
    <citation>Li R, Li J, Cai L, Hu CM, Zhang L. Suppression of adjuvant arthritis by hesperidin in rats and its mechanisms. J Pharm Pharmacol. 2008 Feb;60(2):221-8. doi: 10.1211/jpp.60.2.0011.</citation>
    <PMID>18237470</PMID>
  </reference>
  <reference>
    <citation>Lin-Na S, Yong-Xiu S. Effects of polysaccharides from Gynostemma pentaphyllum (Thunb.), Makino on physical fatigue. Afr J Tradit Complement Altern Med. 2014 Apr 3;11(3):112-7. eCollection 2014.</citation>
    <PMID>25371572</PMID>
  </reference>
  <reference>
    <citation>Longo VD, Mattson MP. Fasting: molecular mechanisms and clinical applications. Cell Metab. 2014 Feb 4;19(2):181-92. doi: 10.1016/j.cmet.2013.12.008. Epub 2014 Jan 16. Review.</citation>
    <PMID>24440038</PMID>
  </reference>
  <reference>
    <citation>Mace, A.E. (1964), Sample Size Determination, New York: Reinhold Publishing Corporation</citation>
  </reference>
  <reference>
    <citation>Marín YE, Wall BA, Wang S, Namkoong J, Martino JJ, Suh J, Lee HJ, Rabson AB, Yang CS, Chen S, Ryu JH. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res. 2007 Oct;17(5):274-83.</citation>
    <PMID>17885582</PMID>
  </reference>
  <reference>
    <citation>Mariño G, Pietrocola F, Madeo F, Kroemer G. Caloric restriction mimetics: natural/physiological pharmacological autophagy inducers. Autophagy. 2014;10(11):1879-82. doi: 10.4161/auto.36413.</citation>
    <PMID>25484097</PMID>
  </reference>
  <reference>
    <citation>Martini C, Pallottini V, De Marinis E, Marino M, Cavallini G, Donati A, Straniero S, Trentalance A. Omega-3 as well as caloric restriction prevent the age-related modifications of cholesterol metabolism. Mech Ageing Dev. 2008 Dec;129(12):722-7. doi: 10.1016/j.mad.2008.09.010. Epub 2008 Sep 26.</citation>
    <PMID>18930075</PMID>
  </reference>
  <reference>
    <citation>Merry BJ. Molecular mechanisms linking calorie restriction and longevity. Int J Biochem Cell Biol. 2002 Nov;34(11):1340-54. Review.</citation>
    <PMID>12200030</PMID>
  </reference>
  <reference>
    <citation>Meydani M, Hasan ST. Dietary polyphenols and obesity. Nutrients. 2010 Jul;2(7):737-51. doi: 10.3390/nu2070737. Epub 2010 Jul 8. Review.</citation>
    <PMID>22254051</PMID>
  </reference>
  <reference>
    <citation>Meyer OC. Safety and security of Daflon 500 mg in venous insufficiency and in hemorrhoidal disease. Angiology. 1994 Jun;45(6 Pt 2):579-84.</citation>
    <PMID>8203791</PMID>
  </reference>
  <reference>
    <citation>Meyer TE, Kovács SJ, Ehsani AA, Klein S, Holloszy JO, Fontana L. Long-term caloric restriction ameliorates the decline in diastolic function in humans. J Am Coll Cardiol. 2006 Jan 17;47(2):398-402.</citation>
    <PMID>16412867</PMID>
  </reference>
  <reference>
    <citation>Mishra R, Joshi D. Jiao Gu Lan (Gynostemma pentaphyllum): The Chinese Rasayan-Current Research Scenario. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2(4): 1483-1502, 2011.</citation>
  </reference>
  <reference>
    <citation>Miwa Y, Yamada M, Sunayama T, Mitsuzumi H, Tsuzaki Y, Chaen H, Mishima Y, Kibata M. Effects of glucosyl hesperidin on serum lipids in hyperlipidemic subjects: preferential reduction in elevated serum triglyceride level. J Nutr Sci Vitaminol (Tokyo). 2004 Jun;50(3):211-8.</citation>
    <PMID>15386934</PMID>
  </reference>
  <reference>
    <citation>Modaghegh MH, Shahabian M, Esmaeili HA, Rajbai O, Hosseinzadeh H. Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteers. Phytomedicine. 2008 Dec;15(12):1032-7. doi: 10.1016/j.phymed.2008.06.003. Epub 2008 Aug 6.</citation>
    <PMID>18693099</PMID>
  </reference>
  <reference>
    <citation>Mostoslavsky R, Chua KF, Lombard DB, Pang WW, Fischer MR, Gellon L, Liu P, Mostoslavsky G, Franco S, Murphy MM, Mills KD, Patel P, Hsu JT, Hong AL, Ford E, Cheng HL, Kennedy C, Nunez N, Bronson R, Frendewey D, Auerbach W, Valenzuela D, Karow M, Hottiger MO, Hursting S, Barrett JC, Guarente L, Mulligan R, Demple B, Yancopoulos GD, Alt FW. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell. 2006 Jan 27;124(2):315-29.</citation>
    <PMID>16439206</PMID>
  </reference>
  <reference>
    <citation>Nielsen IL, Chee WS, Poulsen L, Offord-Cavin E, Rasmussen SE, Frederiksen H, Enslen M, Barron D, Horcajada MN, Williamson G. Bioavailability is improved by enzymatic modification of the citrus flavonoid hesperidin in humans: a randomized, double-blind, crossover trial. J Nutr. 2006 Feb;136(2):404-8.</citation>
    <PMID>16424119</PMID>
  </reference>
  <reference>
    <citation>Ohara T, Muroyama K, Yamamoto Y, Murosaki S. Oral intake of a combination of glucosyl hesperidin and caffeine elicits an anti-obesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial. Nutr J. 2016 Jan 19;15:6. doi: 10.1186/s12937-016-0123-7. Erratum in: Nutr J. 2017 May 12;16(1):28.</citation>
    <PMID>26786000</PMID>
  </reference>
  <reference>
    <citation>Palit S, Kar S, Sharma G, Das PK. Hesperetin Induces Apoptosis in Breast Carcinoma by Triggering Accumulation of ROS and Activation of ASK1/JNK Pathway. J Cell Physiol. 2015 Aug;230(8):1729-39. doi: 10.1002/jcp.24818.</citation>
    <PMID>25204891</PMID>
  </reference>
  <reference>
    <citation>Park C, Moon DO, Choi IW, Choi BT, Nam TJ, Rhu CH, Kwon TK, Lee WH, Kim GY, Choi YH. Curcumin induces apoptosis and inhibits prostaglandin E(2) production in synovial fibroblasts of patients with rheumatoid arthritis. Int J Mol Med. 2007 Sep;20(3):365-72.</citation>
    <PMID>17671742</PMID>
  </reference>
  <reference>
    <citation>Pathak N, Rai AK, Kumari R, Bhat KV. Value addition in sesame: A perspective on bioactive components for enhancing utility and profitability. Pharmacogn Rev. 2014 Jul;8(16):147-55. doi: 10.4103/0973-7847.134249. Review.</citation>
    <PMID>25125886</PMID>
  </reference>
  <reference>
    <citation>Pazoki-Toroudi H, Amani H, Ajami M, Nabavi SF, Braidy N, Kasi PD, Nabavi SM. Targeting mTOR signaling by polyphenols: A new therapeutic target for ageing. Ageing Res Rev. 2016 Nov;31:55-66. doi: 10.1016/j.arr.2016.07.004. Epub 2016 Jul 21. Review.</citation>
    <PMID>27453478</PMID>
  </reference>
  <reference>
    <citation>Phillips T, Leeuwenburgh C. Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction. FASEB J. 2005 Apr;19(6):668-70. Epub 2005 Jan 21.</citation>
    <PMID>15665035</PMID>
  </reference>
  <reference>
    <citation>Pokusaeva K, Fitzgerald GF, van Sinderen D. Carbohydrate metabolism in Bifidobacteria. Genes Nutr. 2011 Aug;6(3):285-306. doi: 10.1007/s12263-010-0206-6. Epub 2011 Feb 16.</citation>
    <PMID>21484167</PMID>
  </reference>
  <reference>
    <citation>Poudyal H, Campbell F, Brown L. Olive leaf extract attenuates cardiac, hepatic, and metabolic changes in high carbohydrate-, high fat-fed rats. J Nutr. 2010 May;140(5):946-53. doi: 10.3945/jn.109.117812. Epub 2010 Mar 24.</citation>
    <PMID>20335636</PMID>
  </reference>
  <reference>
    <citation>Ray S, Bagchi D, Lim PM, Bagchi M, Gross SM, Kothari SC, Preuss HG, Stohs SJ. Acute and long-term safety evaluation of a novel IH636 grape seed proanthocyanidin extract. Res Commun Mol Pathol Pharmacol. 2001 Mar-Apr;109(3-4):165-97.</citation>
    <PMID>11758648</PMID>
  </reference>
  <reference>
    <citation>Razmovski-Naumovski V, Hsun-Wei Huang T, Tran V, et al. Chemistry and pharmacology of Gynostemma pentaphyllum. Phytochemistry Reviews 4:197-219, 2005</citation>
  </reference>
  <reference>
    <citation>Renny RM, Gopakumar G, Mohanan R, et al. Clove bud polyphenols (Clovinol®) reduces hangover and helps faster clearance of acetaldehyde by maintaining endogenous antioxidants and reducing inflammation: A randomized, double-blind, placebo-controlled crossover study. Under Review - Pharmacology Biochemistry &amp; Behavior. 2016.</citation>
  </reference>
  <reference>
    <citation>Rizza S, Muniyappa R, Iantorno M, Kim JA, Chen H, Pullikotil P, Senese N, Tesauro M, Lauro D, Cardillo C, Quon MJ. Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome. J Clin Endocrinol Metab. 2011 May;96(5):E782-92. doi: 10.1210/jc.2010-2879. Epub 2011 Feb 23.</citation>
    <PMID>21346065</PMID>
  </reference>
  <reference>
    <citation>Rojo LE, Ribnicky D, Logendra S, Poulev A, Rojas-Silva P, Kuhn P, Dorn R, Grace MH, Lila MA, Raskin I. In Vitro and in Vivo Anti-Diabetic Effects of Anthocyanins from Maqui Berry (Aristotelia chilensis). Food Chem. 2012 Mar 15;131(2):387-396.</citation>
    <PMID>26279603</PMID>
  </reference>
  <reference>
    <citation>Roohbakhsh A, Parhiz H, Soltani F, Rezaee R, Iranshahi M. Molecular mechanisms behind the biological effects of hesperidin and hesperetin for the prevention of cancer and cardiovascular diseases. Life Sci. 2015 Mar 1;124:64-74. doi: 10.1016/j.lfs.2014.12.030. Epub 2015 Jan 24. Review.</citation>
    <PMID>25625242</PMID>
  </reference>
  <reference>
    <citation>Ruth MR, Port AM, Shah M, Bourland AC, Istfan NW, Nelson KP, Gokce N, Apovian CM. Consuming a hypocaloric high fat low carbohydrate diet for 12 weeks lowers C-reactive protein, and raises serum adiponectin and high density lipoprotein-cholesterol in obese subjects. Metabolism. 2013 Dec;62(12):1779-87. doi: 10.1016/j.metabol.2013.07.006. Epub 2013 Sep 26. Erratum in: Metabolism. 2014 Mar;63(3):e1.</citation>
    <PMID>24075505</PMID>
  </reference>
  <reference>
    <citation>Sanae F, Kamiyama O, Ikeda-Obatake K, Higashi Y, Asano N, Adachi I, Kato A. Effects of eugenol-reduced clove extract on glycogen phosphorylase b and the development of diabetes in db/db mice. Food Funct. 2014 Feb;5(2):214-9. doi: 10.1039/c3fo60514k.</citation>
    <PMID>24336787</PMID>
  </reference>
  <reference>
    <citation>Shai I, Schwarzfuchs D, Henkin Y, Shahar DR, Witkow S, Greenberg I, Golan R, Fraser D, Bolotin A, Vardi H, Tangi-Rozental O, Zuk-Ramot R, Sarusi B, Brickner D, Schwartz Z, Sheiner E, Marko R, Katorza E, Thiery J, Fiedler GM, Blüher M, Stumvoll M, Stampfer MJ; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008 Jul 17;359(3):229-41. doi: 10.1056/NEJMoa0708681. Erratum in: N Engl J Med. 2009 Dec 31;361(27):2681.</citation>
    <PMID>18635428</PMID>
  </reference>
  <reference>
    <citation>Shehata AS, Amer MG, Abd El-Haleem MR, Karam RA. The ability of hesperidin compared to that of insulin for preventing osteoporosis induced by type I diabetes in young male albino rats: A histological and biochemical study. Exp Toxicol Pathol. 2017 Apr 4;69(4):203-212. doi: 10.1016/j.etp.2017.01.008. Epub 2017 Jan 26.</citation>
    <PMID>28132802</PMID>
  </reference>
  <reference>
    <citation>Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, Kurlan R, Molho E, Harrison M, Lew M; Parkinson Study Group. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol. 2002 Oct;59(10):1541-50.</citation>
    <PMID>12374491</PMID>
  </reference>
  <reference>
    <citation>Spadafranca A, Rinelli S, Riva A, Morazzoni P, Magni P, Bertoli S, Battezzati A. Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects. Br J Nutr. 2013 May 28;109(10):1789-95. doi: 10.1017/S0007114512003741. Epub 2012 Oct 9.</citation>
    <PMID>23046862</PMID>
  </reference>
  <reference>
    <citation>Taghizadeh M, Farzin N, Taheri S, Mahlouji M, Akbari H, Karamali F, Asemi Z. The Effect of Dietary Supplements Containing Green Tea, Capsaicin and Ginger Extracts on Weight Loss and Metabolic Profiles in Overweight Women: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Ann Nutr Metab. 2017;70(4):277-285. doi: 10.1159/000471889. Epub 2017 Jun 9.</citation>
    <PMID>28595182</PMID>
  </reference>
  <reference>
    <citation>Tomimori N, Tanaka Y, Kitagawa Y, Fujii W, Sakakibara Y, Shibata H. Pharmacokinetics and safety of the sesame lignans, sesamin and episesamin, in healthy subjects. Biopharm Drug Dispos. 2013 Nov;34(8):462-73. doi: 10.1002/bdd.1862. Epub 2013 Oct 17.</citation>
    <PMID>24014208</PMID>
  </reference>
  <reference>
    <citation>Umeno A, Horie M, Murotomi K, Nakajima Y, Yoshida Y. Antioxidative and Antidiabetic Effects of Natural Polyphenols and Isoflavones. Molecules. 2016 May 30;21(6). pii: E708. doi: 10.3390/molecules21060708. Review.</citation>
    <PMID>27248987</PMID>
  </reference>
  <reference>
    <citation>Ungvari Z, Parrado-Fernandez C, Csiszar A, de Cabo R. Mechanisms underlying caloric restriction and lifespan regulation: implications for vascular aging. Circ Res. 2008 Mar 14;102(5):519-28. doi: 10.1161/CIRCRESAHA.107.168369. Review.</citation>
    <PMID>18340017</PMID>
  </reference>
  <reference>
    <citation>Vallianou NG, Evangelopoulos A, Schizas N, Kazazis C. Potential anticancer properties and mechanisms of action of curcumin. Anticancer Res. 2015 Feb;35(2):645-51. Review.</citation>
    <PMID>25667441</PMID>
  </reference>
  <reference>
    <citation>Varady KA, Bhutani S, Klempel MC, Kroeger CM, Trepanowski JF, Haus JM, Hoddy KK, Calvo Y. Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial. Nutr J. 2013 Nov 12;12(1):146. doi: 10.1186/1475-2891-12-146.</citation>
    <PMID>24215592</PMID>
  </reference>
  <reference>
    <citation>Verdery RB, Walford RL. Changes in plasma lipids and lipoproteins in humans during a 2-year period of dietary restriction in Biosphere 2. Arch Intern Med. 1998 Apr 27;158(8):900-6.</citation>
    <PMID>9570177</PMID>
  </reference>
  <reference>
    <citation>Visnagri A, Kandhare AD, Chakravarty S, Ghosh P, Bodhankar SL. Hesperidin, a flavanoglycone attenuates experimental diabetic neuropathy via modulation of cellular and biochemical marker to improve nerve functions. Pharm Biol. 2014 Jul;52(7):814-28. doi: 10.3109/13880209.2013.870584. Epub 2014 Feb 21.</citation>
    <PMID>24559476</PMID>
  </reference>
  <reference>
    <citation>Wang M, Wang F, Wang Y, Ma X, Zhao M, Zhao C. Metabonomics study of the therapeutic mechanism of Gynostemma pentaphyllum and atorvastatin for hyperlipidemia in rats. PLoS One. 2013 Nov 1;8(11):e78731. doi: 10.1371/journal.pone.0078731. eCollection 2013.</citation>
    <PMID>24223845</PMID>
  </reference>
  <reference>
    <citation>Westphal S, Orth M, Ambrosch A, Osmundsen K, Luley C. Postprandial chylomicrons and VLDLs in severe hypertriacylglycerolemia are lowered more effectively than are chylomicron remnants after treatment with n-3 fatty acids. Am J Clin Nutr. 2000 Apr;71(4):914-20.</citation>
    <PMID>10731497</PMID>
  </reference>
  <reference>
    <citation>Witte AV, Fobker M, Gellner R, Knecht S, Flöel A. Caloric restriction improves memory in elderly humans. Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1255-60. doi: 10.1073/pnas.0808587106. Epub 2009 Jan 26.</citation>
    <PMID>19171901</PMID>
  </reference>
  <reference>
    <citation>Wu X, Xiaofeng X, Shen J, Perricone NV, Preuss HG. Enhanced weight loss from a dietary supplement containing standardized Phaseolus vulgaris extract in overweight men and women. Methods (San Diego, Calif.). 12(13):15-22. 2010.</citation>
  </reference>
  <reference>
    <citation>Xiao L, Ning J, Xu G. Application of Xylo-oligosaccharide in modifying human intestinal function. African Journal of Microbiology Research. (9):2116-9, 2012.</citation>
  </reference>
  <reference>
    <citation>Yanovski JA, Yanovski SZ, Sovik KN, Nguyen TT, O'Neil PM, Sebring NG. A prospective study of holiday weight gain. N Engl J Med. 2000 Mar 23;342(12):861-7.</citation>
    <PMID>10727591</PMID>
  </reference>
  <reference>
    <citation>Zamora-Ros R, Knaze V, Rothwell JA, Hémon B, Moskal A, Overvad K, Tjønneland A, Kyrø C, Fagherazzi G, Boutron-Ruault MC, Touillaud M, Katzke V, Kühn T, Boeing H, Förster J, Trichopoulou A, Valanou E, Peppa E, Palli D, Agnoli C, Ricceri F, Tumino R, de Magistris MS, Peeters PH, Bueno-de-Mesquita HB, Engeset D, Skeie G, Hjartåker A, Menéndez V, Agudo A, Molina-Montes E, Huerta JM, Barricarte A, Amiano P, Sonestedt E, Nilsson LM, Landberg R, Key TJ, Khaw KT, Wareham NJ, Lu Y, Slimani N, Romieu I, Riboli E, Scalbert A. Dietary polyphenol intake in Europe: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Eur J Nutr. 2016 Jun;55(4):1359-75. doi: 10.1007/s00394-015-0950-x. Epub 2015 Jun 17.</citation>
    <PMID>26081647</PMID>
  </reference>
  <results_reference>
    <citation>Mohamadpour AH, Ayati Z, Parizadeh MR, Rajbai O, Hosseinzadeh H. Safety Evaluation of Crocin (a constituent of saffron) Tablets in Healthy Volunteers. Iran J Basic Med Sci. 2013 Jan;16(1):39-46.</citation>
    <PMID>23638291</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2017</study_first_submitted>
  <study_first_submitted_qc>December 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2017</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Body Weight</mesh_term>
    <mesh_term>Weight Gain</mesh_term>
    <mesh_term>Body Weight Changes</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Turmeric extract</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

